MARKET COMPOSITE
AGIO - Agios Pharmaceuticals Inc8:00:00 PM 3/28/2024
Price
$29.12
+ 0.06 (0.21%)
Agios Pharmaceuticals Inc. is a public American pharmaceutical company focused on developing small-molecule anti-cancer therapeutics targeting cancer cell metabolism via the growth factor pathway. Among the proteins under investigation by the company are IDH1 and IDH2. The company was founded in 2008 by Lewis Cantley, Tak Mak and Craig Thompson. Agios is a Delaware corporation headquartered in Cambridge, Massachusetts. The company tendered an initial public offering in July 2013. In 2012, Agios was named among the defendants in a lawsuit against one of its founders, Craig Thompson, alleging that Thompson used research illegally taken from the Abramson Family Cancer Research Institute in research at Agios.
Financials
Quarterly financials
(USD)Dec 2023Q/Q
Revenue7.1MM-4%
Gross Profit6.5MM-
Cost Of Revenue586K-7%
Operating Income-106.3MM+5%
Operating Expenses112.8MM-
Net Income-95.9MM+5%
R&D77.5MM-5%
G&A--
Stock Chart

Short Volume Ratio = Short Volume / All Volume. Source of Short Volume data comes from 

Finra

Moving Average Convergence/Divergence oscillator (MACD) is one of the simplest and most effective momentum indicators available.

Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. RSI oscillates between zero and 100. According to Wilder, RSI is considered overbought when above 70 and oversold when below 30.

Stock news